Schulz-Juergensen Sebastian, Langguth Anna, Eggert Paul
Department of General Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Strasse 3, Haus 9, 24105, Kiel, Germany,
Pediatr Nephrol. 2014 Jul;29(7):1209-13. doi: 10.1007/s00467-014-2756-0. Epub 2014 Feb 2.
Alarm therapy is a long-established first-line therapy for nocturnal enuresis (NE). Desamino-arginine vasopressin (dDAVP) as alternative first-line therapy was shown to increase the prepulse inhibition (PPI) of startle reflexes, thus supporting the hypothesis of a maturational delay of reflex inhibition in NE. Effects of alarm therapy on PPI have not yet been investigated.
The PPI of startle reflexes was measured in 20 children with NE (13 boys, 7 girls, median age 8.5 years, range 5-13) before and after at least 6 weeks of alarm treatment and compared with repeated PPI measurements in 11 healthy controls (7 boys, 4 girls, median age 8 years, range 6-13).
In the NE patients, PPI increased from a median baseline of 20-46% under alarm therapy (p = 0.005), with a reduction from a median of 7 to 2 wet nights per week (p = 0.002). The controls showed no difference in PPI (52% median at first, 40% at second measurement, p = 0.966).
The increase of PPI trough alarm therapy was comparable with that under dDAVP, suggesting an analogous method of action and explaining the alternative or synergistic effect of both therapies. In addition, it further substantiates the hypothesis of a maturational delay of reflex control in NE.
警报疗法是治疗夜间遗尿症(NE)的一种长期确立的一线疗法。去氨基精氨酸加压素(dDAVP)作为替代一线疗法,已被证明可增强惊吓反射的前脉冲抑制(PPI),从而支持NE中反射抑制成熟延迟的假说。警报疗法对PPI的影响尚未得到研究。
对20名NE患儿(13名男孩,7名女孩,中位年龄8.5岁,范围5 - 13岁)在进行至少6周的警报治疗前后测量惊吓反射的PPI,并与11名健康对照者(7名男孩,4名女孩,中位年龄8岁,范围6 - 13岁)重复测量的PPI进行比较。
在NE患者中,警报治疗下PPI从基线中位数20%增加到46%(p = 0.005),每周尿床次数从中位数7次减少到2次(p = 0.002)。对照组的PPI没有差异(第一次测量中位数为52%,第二次测量为40%,p = 0.966)。
通过警报疗法使PPI增加的情况与使用dDAVP时相当,这表明二者作用方式类似,并解释了两种疗法的替代或协同效应。此外,这进一步证实了NE中反射控制成熟延迟的假说。